TickerFacts.

Company research / HCA

HCA Healthcare, Inc. (HCA)

Build a valuation ↗↓ Download CSV

CIK 0000860730 · NYSE · Services-General Medical & Surgical Hospitals, NEC

  • Sector Services
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, HCA Healthcare, Inc. reported revenue of $75.60B. Revenue grew 7.1% from the prior annual period. Over the twelve months to 2026-03-31, revenue was $76.39B.

Key ratios (year ended 2025-12-31)

9.0%
Net margin
7.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-28

Headquarters locality: Nashville · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-03-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-03-31		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$76.39B$75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
Depreciation & Amortization$3.59B$3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Net Income$6.79B$6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
EPS (Diluted)n/a$28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Total Assets$61.45B$60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Total Liabilitiesn/an/an/an/an/an/an/a$45.62B$42.12B$41.59B$39.39B
Long-Term Debt$44.37B$44.28B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Shareholders' Equity-$2.98B-$2.77B$555.00M$1.06B-$73.00M$1.49B$2.89B-$565.00M-$2.92B-$5.00B-$5.63B
Cash & Equivalents$940.00M$1.04B$1.93B$935.00M$908.00M$1.45B$1.79B$621.00M$502.00M$732.00M$646.00M
Operating Cash Flow$13.00B$12.64B$10.51B$9.43B$8.52B$8.96B$9.23B$7.60B$6.76B$5.43B$5.65B
Capital Expenditures$5.07B$4.94B$4.88B$4.74B$4.39B$3.58B$2.83B$4.16B$3.57B$3.02B$2.76B
Free Cash Flow$7.93B$7.69B$5.64B$4.69B$4.13B$5.38B$6.40B$3.44B$3.19B$2.41B$2.89B
Share Repurchases$9.13B$10.07B$6.04B$3.81B$7.00B$8.21B$441.00M$1.03B$1.53B$2.05B$2.75B
Dividends Paid$682.00M$679.00M$690.00M$661.00M$653.00M$624.00M$153.00M$550.00M$487.00M$0n/a
Shares Outstanding222.53M224.61M249.98M265.54M277.38M305.48M339.43M338.45M342.90M350.09M370.54M
Dividends Per Sharen/a$2.88$2.64$2.40$2.24$1.92$0.43$1.60$1.40n/an/a
Weighted Average Diluted Sharesn/a239.50M261.81M276.41M294.67M328.75M343.61M348.23M355.30M372.22M395.85M
EPS (Basic)n/a$28.70$22.27$19.25$19.43$21.52$11.10$10.27$10.90$6.12$7.53

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView